Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's molecular size and shape determine how it interacts with metabolic enzymes and transporters. Larger drugs may struggle to reach enzyme active sites, altering their metabolic pathways. These physicochemical properties fundamentally influence whether a drug can access the liver enzymes responsible for metabolism, directly affecting how quickly the body processes the drug.

Lipophilicity, a drug's ability to dissolve in lipids, determines its capacity to cross cell membranes and interact with liver enzymes. Lipophilic drugs more readily penetrate cellular barriers and reach metabolic enzymes, influencing their metabolism rates. This property also affects how enzyme inducers like phenobarbital interact with drugs, since these inducers are themselves lipophilic compounds.

A drug's pKa establishes its ionization state, affecting solubility and absorption, which in turn influences metabolism. Acidic drugs tend to undergo phase II reactions like glucuronidation, while basic drugs typically undergo phase I reactions such as oxidation or hydroxylation. The drug's acidity or basicity is essential in determining which metabolic reactions it undergoes.

Enzyme induction increases the activity of drug-metabolizing enzymes, accelerating drug metabolism. Inducers like phenobarbital, rifampicin, and phenytoin are lipophilic compounds with long elimination half-lives that act as substrates for the induced enzymes. Enzyme induction can decrease a drug's pharmacological activity by increasing its metabolism rate, potentially reducing therapeutic effectiveness.

Steric hindrance from bulky substituents can impede enzyme access to the drug, slowing metabolism. Electronic features alter the drug's reactivity with metabolic enzymes, influencing how readily the drug undergoes metabolic reactions. Together, these characteristics determine the drug's interaction with enzyme active sites and its susceptibility to phase I reactions like oxidation of aliphatic and aromatic carbon containing systems.

A drug's stereochemical nature, particularly the presence of chiral centers, determines how metabolic enzymes process it. Different stereoisomers can follow distinct metabolic pathways and produce different metabolites. This means two drugs with identical chemical formulas but different three-dimensional structures may be metabolized at different rates or undergo different metabolic reactions.

Environmental chemicals like polycyclic aromatic hydrocarbons, certain pesticides, and industrial chemicals can induce drug-metabolizing enzymes, increasing metabolism and reducing drug efficacy. Conversely, chemicals found in grapefruit juice inhibit these enzymes, leading to increased drug concentrations and potential adverse effects. Understanding these environmental influences is vital for predicting drug efficacy and preventing harmful drug-drug interactions.